BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2828691)

  • 1. B-cell lymphoproliferation and lymphomagenesis are associated with clonotypic intracellular terminal regions of the Epstein-Barr virus.
    Brown NA; Liu CR; Wang YF; Garcia CR
    J Virol; 1988 Mar; 62(3):962-9. PubMed ID: 2828691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro.
    Sugden B
    Rev Infect Dis; 1982; 4(5):1048-61. PubMed ID: 6293034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient.
    Roncella S; Di Celle PF; Cutrona G; Carbone A; Sessarego M; Landonio G; Foà R; Rowe M; Ferrarini M
    Leuk Lymphoma; 1993 Jan; 9(1-2):157-64. PubMed ID: 8386576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation.
    Raab-Traub N; Flynn K
    Cell; 1986 Dec; 47(6):883-9. PubMed ID: 3022942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens.
    Ambinder RF; Lambe BC; Mann RB; Hayward SD; Zehnbauer BA; Burns WS; Charache P
    Mol Cell Probes; 1990 Oct; 4(5):397-407. PubMed ID: 2177846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.
    Kurth J; Hansmann ML; Rajewsky K; Küppers R
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4730-5. PubMed ID: 12665622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epstein-Barr virus infection--a lympho- and epitheliotropic infection].
    Näher H; Petzoldt D
    Hautarzt; 1992 Mar; 43(3):114-9. PubMed ID: 1315723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs.
    Bornkamm GW; Delius H; Zimber U; Hudewentz J; Epstein MA
    J Virol; 1980 Sep; 35(3):603-18. PubMed ID: 6252328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers.
    Kaplan MA; Ferry JA; Harris NL; Jacobson JO
    Am J Clin Pathol; 1994 May; 101(5):590-6. PubMed ID: 8178765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic and phenotypic alterations in Epstein-Barr virus-associated lymphoma.
    Ohshima K; Suzumiya J; Kanda M; Haraoka S; Kawasaki C; Shimazaki K; Kikuchi M
    Histopathology; 1999 Dec; 35(6):539-50. PubMed ID: 10583578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epstein-Barr virus (EBV)].
    Seigneurin JM
    Rev Prat; 1999 Dec; 49(20):2217-21. PubMed ID: 10731805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of natural Epstein-Barr virus isolates from infectious mononucleosis patients and healthy carriers.
    Lung ML; Chang RS; Jones JH
    J Virol; 1988 Oct; 62(10):3862-6. PubMed ID: 2901499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.
    Whitehurst CB; Li G; Montgomery SA; Montgomery ND; Su L; Pagano JS
    mBio; 2015 Oct; 6(5):e01574-15. PubMed ID: 26489865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Latent EBV infection and pathogenesis of tumor].
    Osato G
    Uirusu; 1990 Jun; 40(1):28-9. PubMed ID: 1962972
    [No Abstract]   [Full Text] [Related]  

  • 15. The Epstein-Barr Virus and malignancy: molecular evidence.
    Pagano JS
    Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():797-805. PubMed ID: 50897
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus.
    Chappuis BB; Müller-Hermelink HK
    Environ Health Perspect; 1990 Aug; 88():237-41. PubMed ID: 2176977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structural organization of the Epstein-Barr virus genome].
    D'iachenko AG
    Eksp Onkol; 1984; 6(4):3-10. PubMed ID: 6209094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent active Epstein-Barr virus infection and atypical lymphoproliferation. Report of two cases.
    Krueger GR; Papadakis T; Schaefer HJ
    Am J Surg Pathol; 1987 Dec; 11(12):972-81. PubMed ID: 2825551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-associated primary B-cell lymphoproliferative disorder of the cerebellum in an immune competent man.
    Demetrick DJ; Hamilton MG; Curry B; Tranmer BI
    Cancer; 1992 Jul; 70(2):519-28. PubMed ID: 1319819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.